MedTrace Logo

Prevention of P. Vivax Malaria During Pregnancy in Bolivia

NCT00290420 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2013-05-22

No results posted yet for this study

Summary

The purpose of this study is to determine which, between weekly prophylaxis or malaria attack treatment, both by chloroquine, is the most appropriate way to protect women and foetus from P. vivax malaria infection during pregnancy.

Conditions

Interventions

DRUG

Chloroquine profilaxis

Prevention: Give a profilaxis with chloroquine once a week to prevent Plasmodium vivax malaria attacks and to prevent harmfull effect on birth outcomes

Sponsors & Collaborators

  • Instituto Nacional de Laboratorios de Salud (INLASA)

    collaborator UNKNOWN

  • Pan American Health Organization

    collaborator OTHER

  • Ministry of Health, Bolivia

    collaborator OTHER_GOV

  • Institut de Recherche pour le Developpement

    lead OTHER_GOV

Principal Investigators

  • Michel Cot, MD-PhD · Institut de Recherche pour le Developpement

  • Laurent Brutus, MD-MSc · Institut de Recherche pour le Développement, IRD, Bolivia

  • Agnès Le Port, MSc · Institut de Recherche pour le Développement, IRD, Bolivia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-11-30
Completion
2007-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00290420 on ClinicalTrials.gov